Piperazine → 8-Chloro-5,11-dihydro-11-(1-piperazinyl)[1]benzothiepino[4,3-b]pyridine

HRID 1647252Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1647252
[Cl:1][C:2]1[CH:17]=[CH:16][C:5]2[CH:6](Cl)[C:7]3[C:12]([CH2:13][S:14][C:4]=2[CH:3]=1)=[CH:11][CH:10]=[CH:9][N:8]=3.[NH:18]1[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]1.[OH-].[Na+]>O1CCCC1>[Cl:1][C:2]1[CH:17]=[CH:16][C:5]2[CH:6]([N:18]3[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]3)[C:7]3[C:12]([CH2:13][S:14][C:4]=2[CH:3]=1)=[CH:11][CH:10]=[CH:9][N:8]=3

Komponenten

5

Versuchsvorschrift

Add a solution of 8,11-dichloro-5,11-dihydro[1]benzothiepino[4,3-b]pyridine (8.15 g, 0.029 mol) in tetrahydrofuran (100 mL) to a stirred suspension of piperazine (28.9 g, 0.34 mol) in tetrahydrofuran (290 mL) at 18°-19° C. over 20 minutes. Stir the mixture for 4 hours at room temperature and then pour it into 2.5M aqueous NaOH (250 mL) containing ice. Separate the layers, and extract the aqueous portion with EtOAc (3×100 mL). Combine the organic portions, and wash with H2O (3×75 mL) and brine (150 mL). Dry the mixture over MgSO4, filter, and concentrate the organic layer in vacuo to obtain the crude product (8.9 g). Purify the crude product via flash chromatography (9:1:0.125 CH2Cl2 /MeOH/NH4OH) to obtain the title compound (7.6 g, 78% yield).

Aufarbeitung

  1. additioncontaining ice
  2. customSeparate the layers
  3. extractionextract the aqueous portion with EtOAc (3×100 mL)
  4. washCombine the organic portions, and wash with H2O (3×75 mL) and brine (150 mL)
  5. dry with materialDry the mixture over MgSO4
  6. filtrationfilter
  7. concentrationconcentrate the organic layer in vacuo
  8. customto obtain the crude product (8.9 g)
  9. customPurify the crude product via flash chromatography (9:1:0.125 CH2Cl2 /MeOH/NH4OH)

Quellen und Nachweise

ORD-Eintrag
ord-7b179e8ebc574687b8530206fafb0149
Quelldatensatz
uspto-grants-1995_07
Patentnummer
US05430032

Notizen zur Reaktion

Wird geladen…